Q-omics provides the consensus-scored SPATA31E2P profile across patient tissues and cancer cell-line models. SPATA31E2P expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in CHOL. Additionally, SPATA31E2P RNA expression shows 5,079 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight CHOL, and STAD as cancer lineages where SPATA31E2P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for SPATA31E2P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes SPATA31E2P survival associations across molecular data types. SPATA31E2P RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

SPATA31E2P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	CHOL (108)	view →

This table ranks reproducible SPATA31E2P RNA expression–survival associations across cancer types. High SPATA31E2P expression shows unfavorable associations in CHOL, STAD, CESC and KIRP, but favorable associations in OV and SKCM. The CHOL Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify CHOL as the clearest survival context for SPATA31E2P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
STAD	DFS	Tertile	II,III,IV	0.278	0.719	<.001	75	view →
OV	DFS	Tertile	III,IV	0.369	0.146	.016	42	view →
CESC	OS	Tertile	All	0.121	0.591	.003	36	view →
KIRP	DFS	Tertile	II,III,IV	0.038	0.783	<.001	36	view →
SKCM	OS	Tertile	All	0.656	0.301	.026	27	view →

Pink = unfavorable, green = favorable. all 11 lineages →

SPATA31E2P-CHOL (OS)

Kaplan–Meier survival curve for SPATA31E2P RNA expression in CHOL: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with SPATA31E2P in patient tissues and cancer cell lines. In patient samples, SPATA31E2P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,079	STAD (4941)	view →
RNA	2,120	UCEC (689)	view →